Kazia Therapeutics (KZIA) Change in Working Capital (2021 - 2022)

Kazia Therapeutics' (KZIA) quarterly Change in Working Capital came in at -$427164.7 in Q4 2022, up 64.33% YoY from -$259938.6 in Q4 2021, and up 64.33% on a QoQ basis from -$1.2 million in Q4 2021.

Kazia Therapeutics (KZIA) Change in Working Capital (2021 - 2022) Analysis & Trends

Kazia Therapeutics (KZIA) has 2 years of Change in Working Capital data on file, last reported at -$427164.7 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Kazia Therapeutics 4.22 Bn 4.22 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 -427,164.70
Dec 31, 2022 -427,164.70
Dec 31, 2021 -1.20 Mn
Dec 31, 2021 -1.20 Mn